Bone Loss Recruiting Phase 4 Trials for Bictegravir (DB11799)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03916328BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) StudyTreatment